MedTrace Logo

Zinc Status and Growth in Cystic Fibrosis

NCT04302428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-03-20

No results posted yet for this study

Summary

The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.

Conditions

Interventions

BIOLOGICAL

Serum Zn

The investigators will obtain an additional 2 mL of blood in an extra tube. This will be collected at the same time blood is collected for the participant's yearly CF screening labs so as to minimize additional needle sticks.

BIOLOGICAL

Red Blood Cell Zn

If the participant is greater or equal than 5 kg, an additional 2 mL of blood will be obtained in an extra tube. This will be collected at the same time blood is collected for the participant's yearly CF screening labs so as to minimize additional needle sticks.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Clement Ren, MD · Indiana University

Eligibility

Min Age
3 Months
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-29
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302428 on ClinicalTrials.gov